piperonyl butoxide has been researched along with decabromobiphenyl ether in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Degawa, M; Gamou, T; Inoue, K; Kodama, Y; Nemoto, K; Nishikawa, A; Ozawa, S; Sakamoto, Y; Takahashi, M; Taketa, Y; Yoshida, M | 1 |
1 other study(ies) available for piperonyl butoxide and decabromobiphenyl ether
Article | Year |
---|---|
Different pathways of constitutive androstane receptor-mediated liver hypertrophy and hepatocarcinogenesis in mice treated with piperonyl butoxide or decabromodiphenyl ether.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Body Weight; Cell Proliferation; Constitutive Androstane Receptor; Halogenated Diphenyl Ethers; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Organ Size; Piperonyl Butoxide; Receptors, Cytoplasmic and Nuclear | 2013 |